These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 17038905

  • 1. Sirolimus interferes with iron homeostasis in renal transplant recipients.
    Maiorano A, Stallone G, Schena A, Infante B, Pontrelli P, Schena FP, Grandaliano G.
    Transplantation; 2006 Oct 15; 82(7):908-12. PubMed ID: 17038905
    [Abstract] [Full Text] [Related]

  • 2. Study of anemia after late introduction of everolimus in the immunosuppressive treatment of renal transplant patients.
    Sánchez Fructuoso A, Calvo N, Moreno MA, Giorgi M, Barrientos A.
    Transplant Proc; 2007 Sep 15; 39(7):2242-4. PubMed ID: 17889151
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium.
    Augustine JJ, Rodriguez V, Padiyar A, Bodziak KA, Schulak JA, Hricik DE.
    Transplantation; 2008 Aug 27; 86(4):548-53. PubMed ID: 18724224
    [Abstract] [Full Text] [Related]

  • 5. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
    Malyszko J, Malyszko JS, Mysliwiec M.
    Transplant Proc; 2009 Oct 27; 41(8):3056-9. PubMed ID: 19857675
    [Abstract] [Full Text] [Related]

  • 6. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.
    Stallone G, Infante B, Schena A, Battaglia M, Ditonno P, Loverre A, Gesualdo L, Schena FP, Grandaliano G.
    J Am Soc Nephrol; 2005 Dec 27; 16(12):3755-62. PubMed ID: 16236802
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
    Uslu A, Töz H, Sen S, Alkan FT, Nart A, Aykas A, Doğan M, Postaci H, Sahin T, Simşek C.
    Transplant Proc; 2009 Mar 27; 41(2):756-63. PubMed ID: 19328973
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Causes of anemia in renal transplant recipients.
    Karakuş S, Kanbay M, Köseoğlu HK, Colak T, Haberal M.
    Transplant Proc; 2004 Mar 27; 36(1):164-5. PubMed ID: 15013334
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
    Zadrazil J, Horák P, Horcicka V, Zahálková J, Strébl P, Hrubý M.
    Kidney Blood Press Res; 2007 Mar 27; 30(2):108-16. PubMed ID: 17374961
    [Abstract] [Full Text] [Related]

  • 13. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Mar 27; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence of anemia in renal transplant patients: results from MOST, an observational trial.
    Fernández Fresnedo G, Palomar R, Rodrigo E, Ruiz JC, de Francisco AL, Cotorruelo JG, Arias M.
    Transplant Proc; 2005 Nov 27; 37(9):3821-2. PubMed ID: 16386550
    [Abstract] [Full Text] [Related]

  • 17. The effect of sirolimus in the development of chronic allograft nephropathy.
    Gürkan A, Kaçar S, Erdoğdu U, Varilsüha C, Kandemir G, Karaca C, Akman F.
    Transplant Proc; 2008 Nov 27; 40(1):114-6. PubMed ID: 18261561
    [Abstract] [Full Text] [Related]

  • 18. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
    Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M.
    Am J Hematol; 2006 Nov 27; 81(11):832-7. PubMed ID: 16929540
    [Abstract] [Full Text] [Related]

  • 19. Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy.
    Yavuz A, Akbaş SH, Tuncer M, Kolağasi O, Cetinkaya R, Gürkan A, Demirbaş A, Gultekin M, Akaydin M, Ersoy F, Yakupoğlu G.
    Transplant Proc; 2004 Nov 27; 36(1):41-3. PubMed ID: 15013295
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.